A luminal breast cancer genome atlas: Progress and barriers

Journal of Steroid Biochemistry and Molecular Biology

Volumn 106, Issue 1-5, 2007, Pages 125-129

  Ellis, Matthew J ^a   Dixon, Michael ^c   Dowsett, Mitch ^b   Nagarajan, Rakesh ^a   Mardis, Elaine ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Luminal breast cancer genome atlas

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; LETROZOLE; RNA; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER GENOME ATLAS; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DATA BASE; DNA DAMAGE; DNA FINGERPRINTING; DNA SEQUENCE; ESTROGEN ACTIVITY; FROZEN SECTION; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION REGULATION; GENE LIBRARY; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; LONG TERM CARE; OUTCOMES RESEARCH; SOMATIC MUTATION; TUMOR GENE;

BASE SEQUENCE; BIOPSY; BREAST NEOPLASMS; DATABASES, FACTUAL; ENDOCRINE SYSTEM; GENE EXPRESSION PROFILING; GENOME, HUMAN; HUMANS; NEOADJUVANT THERAPY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTOR, ERBB-2; TREATMENT OUTCOME;

EID: 34548387043     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2007.05.011     Document Type: Article

References (17)

1. Sjoblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W., and Velculescu V.E. The consensus coding sequences of human breast and colorectal cancers. Science 314 (2006) 268-274
2. Fridlyand J., Snijders A.M., Ylstra B., Li H., Olshen A., Segraves R., Dairkee S., Tokuyasu T., Ljung B.M., Jain A.N., McLennan J., Ziegler J., Chin K., Devries S., Feiler H., Gray J.W., Waldman F., Pinkel D., and Albertson D.G. Breast tumor copy number aberration phenotypes and genomic instability. BMC Cancer 6 (2006) 96
3. Chin K., DeVries S., Fridlyand J., Spellman P.T., Roydasgupta R., Kuo W.L., Lapuk A., Neve R.M., Qian Z., Ryder T., Chen F., Feiler H., Tokuyasu T., Kingsley C., Dairkee S., Meng Z., Chew K., Pinkel D., Jain A., Ljung B.M., Esserman L., Albertson D.G., Waldman F.M., and Gray J.W. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10 (2006) 529-541
4. Fan C., Oh D.S., Wessels L., Weigelt B., Nuyten D.S., Nobel A.B., van't Veer L.J., and Perou C.M. Concordance among gene-expression-based predictors for breast cancer. N. Engl. J. Med. 355 (2006) 560-569
5. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
6. Ma C.X., and Ellis M.J. Neoadjuvant endocrine therapy for locally advanced breast cancer. Semin. Oncol. 33 (2006) 650-656
7. Paez J.G., Lin M., Beroukhim R., Lee J.C., Zhao X., Richter D.J., Gabriel S., Herman P., Sasaki H., Altshuler D., Li C., Meyerson M., and Sellers W.R. Genome coverage and sequence fidelity of phi29 polymerase-based multiple strand displacement whole genome amplification. Nucleic Acids Res. 32 (2004) e71
8. Ellis M.J., Coop A., Singh B., Mauriac L., Llombert-Cussac A., Janicke F., Miller W.R., Evans D.B., Dugan M., Brady C., Quebe-Fehling E., and Borgs M. Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial. J. Clin. Oncol. 19 (2001) 3808-3816
9. Ellis M.J., Tao Y., Young O., White S., Proia A.D., Murray J., Renshaw L., Faratian D., Thomas J., Dowsett M., Krause A., Evans D.B., Miller W.R., and Dixon J.M. Estrogen-independent proliferation is present in estrogen-receptor HER2-positive primary breast cancer after neoadjuvant letrozole. J. Clin. Oncol. 24 (2006) 3019-3025
10. Ewing B., Hillier L., Wendl M.C., and Green P. Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res. 8 (1998) 175-185
11. Ewing B., and Green P. Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res. 8 (1998) 186-194
12. Stephens M., Sloan J.S., Robertson P.D., Scheet P., and Nickerson D.A. Automating sequence-based detection and genotyping of SNPs from diploid samples. Nat. Genet. 38 (2006) 375-381
13. Nickerson D.A., Tobe V.O., and Taylor S.L. PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res. 25 (1997) 2745-2751
14. Zhang J., Wheeler D.A., Yakub I., Wei S., Sood R., Rowe W., Liu P.P., Gibbs R.A., and Buetow K.H. SNPdetector: a software tool for sensitive and accurate SNP detection. PLoS Comput. Biol. 1 (2005) e53
15. Ng P.C., and Henikoff S. Predicting deleterious amino acid substitutions. Genome Res. 11 (2001) 863-874
16. Ng P.C., and Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 31 (2003) 3812-3814
17. Bao L., Zhou M., and Cui Y. nsSNPAnalyzer: identifying disease-associated nonsynonymous single nucleotide polymorphisms. Nucleic Acids Res. 33 (2005) W480-W482